Literature DB >> 3812624

Two cases of downbeat nystagmus and oscillopsia associated with carbamazepine.

G A Chrousos, R Cowdry, M Schuelein, A S Abdul-Rahim, V Matsuo, J N Currie.   

Abstract

Downbeat nystagmus is often associated with structural lesions at the craniocervical junction, but has occasionally been reported as a manifestation of metabolic imbalance or drug intoxication. We recorded the eye movements of two patients with reversible downbeat nystagmus related to carbamazepine therapy. The nystagmus of both patients resolved after reduction of the serum carbamazepine levels. Neuroradiologic investigations including magnetic resonance imaging scans in both patients showed no evidence of intracranial abnormality. In patients with downbeat nystagmus who are taking anticonvulsant medications, consideration should be given to reduction in dose before further investigation is undertaken.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3812624     DOI: 10.1016/s0002-9394(14)74231-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Downbeat nystagmus: characteristics and localization of lesions.

Authors:  R D Yee
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 2.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 3.  Pharmacological treatment effects on eye movement control.

Authors:  James L Reilly; Rebekka Lencer; Jeffrey R Bishop; Sarah Keedy; John A Sweeney
Journal:  Brain Cogn       Date:  2008-12       Impact factor: 2.310

4.  Anticonvulsant-induced downbeat nystagmus in epilepsy.

Authors:  Dongyan Wu; Roland D Thijs
Journal:  Epilepsy Behav Case Rep       Date:  2015-08-27

5.  Transient Positive Horizontal Head Impulse Test in Pregabalin Intoxication.

Authors:  Seong-Hae Jeong; Yong Soo Kim; Ju-Hoen Lee; Hyunjin Jo; Ae Young Lee; Jae-Moon Kim
Journal:  J Epilepsy Res       Date:  2015-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.